Results 151 to 160 of about 1,213 (179)
Some of the next articles are maybe not open access.

Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations

Transfusion Medicine Reviews, 2016
Red blood cell (RBC) sensitization occurs in some women in response to exposure to paternally derived RBC antigens during pregnancy or to nonself antigens on transfused RBCs during their lifetime. Once sensitized, future pregnancies may be at risk for hemolytic disease of the fetus and newborn.
Jeanne E, Hendrickson, Meghan, Delaney
openaire   +2 more sources

Hemolytic disease of the fetus and newborn caused by anti‐Lan

Transfusion, 2013
BackgroundAntibodies to the high‐incidence red blood cell (RBC) antigen Lan (Langereis) are typically immunoglobulin G and have been shown to fix complement and cause hemolysis of Lan antigen–positive RBCs. Only three cases of hemolytic disease of the fetus and newborn (HDFN) have been reported involving anti‐Lan and all have been characterized as ...
Sarah, Brooks, Jerry E, Squires
openaire   +2 more sources

Consensus in prenatal management of Hemolytic disease of the fetus and newborn

Best Practice & Research Clinical Obstetrics & Gynaecology
Hemolytic Disease of the Fetus and Newborn (HDFN) is complication caused by maternal alloantibodies crossing the placenta and leading to the destruction of fetal red blood cells. While RhD is the most common antigen causing HDFN, Kell alloimmunization is the most severe. The assessment of HDFN risk begins with identifying the fetal antigen status.
Brittany Jill Arkerson   +2 more
openaire   +2 more sources

Mouse Model of Hemolytic Disease of the Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn (HDFN) is caused by the placental transfer of maternal red blood cell (RBC) alloantibodies into the fetal circulation which then targets paternally derived RBC antigens expressed on the fetal RBC. The resulting anemia in the fetus/newborn can lead to grave clinical consequences including hydrops fetalis ...
Hirotomo, Nakahara   +4 more
openaire   +2 more sources

Hemolytic Disease of the Fetus and Newborn

2022
Pedro Argoti   +2 more
openaire   +1 more source

Hemolytic Disease of the Fetus and Newborn

Medical Clinics of North America, 1965
P, Levine, W, Pollack
openaire   +2 more sources

Hemolytic Disease of the Fetus and Newborn: Historical and Current State

Clinics in Laboratory Medicine, 2021
Jillian Baker
exaly  

Hemolytic disease of the fetus and newborn

2005
Peter E. Waldron, William J. Cashore
openaire   +1 more source

Hemolytic Disease of the Fetus and Newborn

2004
Lawrence D. Petz, George Garratty
openaire   +1 more source

[The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2011
Hemolytic disease of the fetus and newborn (HDFN) is a consequence of maternal alloimmunization against fetal red blood cell antigens. Alloimmunization against D antigen from Rhesus (Rh) blood group system is particularly important because of its strong immunogenicity.
Starčević, M   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy